According to the International Olympics Community (2021), the substances most commonly used or misused by elite athletes across countries, sports and genders are alcohol, nicotine and cannabis. A 2018 meta-analysis found that 19% of athletes and 21.1% of former athletes reported symptoms of alcohol use disorder. 8,2% of athletes had gambling problems. A 2020 study …
This workshop aims to explore the use of psychedelic-assisted psychotherapy (PAP) in treating patients with addiction, focusing on substances like LSD and psilocybin. As addiction continues to challenge traditional therapeutic methods, emerging research highlights the promising role of psychedelics in treating substance use disorders. The workshop will provide participants with a comprehensive understanding of how …
Background Substance use disorder (SUD) is a well-recognized comorbidity in schizophrenia spectrum disorders, and rates of substance use are significantly higher among patients with first-episode psychosis (FEP) than in the general population (1). When a patient presenting with FEP has co-occurring substance use, such as cannabis or stimulant use, it can be extremely difficult to …
Substance-induced psychosis or psychosis with substance use? Read More »
Intergenerational trauma (IGT) refers to the transmission of trauma from one generation to the next, significantly impacting individuals with substance use disorders (SUD) and their families. This keynote presentation will explore the intricate connection between IGT and SUD, drawing on recent research that demonstrates how trauma can influence neurodevelopment, attachment, and addiction vulnerability across generations. …
1. Prevalence of Psychoactive Substance Use and its Associated Factors in Sierra Leone – Abdul Jalloh (Sierra Leone) 2. Opiate Agonist Treatment and Harm Reduction in Morocco: Insight and Outcomes off 15 Years Experiences – Fatima Elomari (Morocco) 3. Evolution of Addiction Management in Senegal: Issues and Perspectives – Idrissa Ba (Senegal) 4. SUD in …
1. Untangling Treatment of Individuals with Stimulant Use Disorder: Should We Address Comorbidity or Substance Use First? – Ali Farhoudian (Iran) 2. Rethinking Stimulant Use Treatment: Moving Beyond Traditional Models – Ramin Radfar (Iran) 3. Contextualization of Evidence-Based Behavioral Treatment for Individuals with Stimulant Use Disorder in Low-Income Countries – Alireza Noroozi (Afghanistan) 4. Contingency …
1. Novel Withdrawal Management Approaches for Unprecedented Opioid Tolerances – Pouya Azar, James Wong, Anil Maharaj, Glenn Sammis, Dan Bizzotto, Borna Noureddin, Chris Haslam (Canada) 2. Initiation of OAT: Rapid Buprenorphine Initiations and High Dose Methadone Initiations – Pouya Azar, James Wong, Anil Maharaj, Glenn Sammis, Dan Bizzotto, Borna Noureddin, Chris Haslam (Canada) 3. Digital …
Innovative Solutions and Approaches in Fentanyl Era Read More »
Cannabis/Cannabinoids for Clinical Management of Pain – Jag Khalsa (USA), Marc Potenza (USA), Gregory Bunt (USA), Ahmed Yousif Ali (UAE)
1. Treatment retention and associated factors among women with Drug dependence: A longitudinal study – Dinesh M 2. Consensus Recommendations on Benzodiazepine Deprescribing – Jaden Brandt
1. The Cannabis Consumption Act in Germany as the first step towards the controlled distribution of cannabis to adults for recreational purposes in Germany and blocking reform opponents in politics and addiction support – Ingo Ilja Michels 2. Employment barriers experienced by IPS employment specialists and patients in Substance Use Disorders (SUD) treatment – Erlend …
